In addition, the book extends its exploration to the broader influence of ApoE on cognitive decline and other neurological conditions, metabolic health, liver function, cancer risk, and immune modulation. With a strong focus on the pharmacogenetics of ApoE, the book paves the way for precision medicine, offering insights into how ApoE genotypes influence medication responses and therapeutic strategies. Future prospects and challenges in harnessing ApoE for disease management are discussed, alongside its role in infectious diseases, genetic engineering innovations, and targeted drug delivery systems.
Table of Contents
1. Apolipoprotein E (ApoE): Structural Insights, Functionality, and Genetic Variability2. Apolipoprotein E and Cardiovascular Pathophysiology: A Comprehensive Exploration
3. Apolipoprotein E in Alzheimer's Disease: Genetic Predisposition and Mechanistic Implications
4. Apolipoprotein E and Neurological Disorders: Beyond Alzheimer's Disease
5. Apolipoprotein E's Impact on Metabolic Syndrome: A Systematic Analysis
6. Apolipoprotein E and Liver Health: Implications in Lipid Metabolism and Disease
7. Apolipoprotein E and its Role in Cancer: Insights into Carcinogenic Associations
8. Apolipoprotein E's Immune Mediation: Implications in Inflammatory Disorders
9. Pharmacogenetics of Apolipoprotein E: Precision Medicine and Therapeutic Implications
10. Challenges and Prospects in Targeting ApoE for Disease Management
11. Apolipoprotein E and Infectious Diseases: A Framework for Therapeutic Developments
12. Genetic Engineering of Apolipoprotein E: Innovations and Clinical Applications
13. Apolipoprotein E and Precision Medicine: Individualized Disease Management Approaches
14. Apolipoprotein E in Drug Delivery Systems: Targeted Pharmacotherapeutics
15. Apolipoprotein E and Autoimmune Disorders: Therapeutic Frontiers

